An Analysis of the Evolution of the Written Description Requirement vis-a-vis DNA and Biotechnological Inventions
Abstract:The Federal Circuit uses particular patent doctrines as policy levers to control the nature of the nation's patent output. Most recently, the court has looked to the narrow implementation of the written description doctrine to limit the scope of biotechnology patents in general and DNA patents in particular. Recent case-law now indicates a slow evolution within the Federal Circuit to loosen this control and broaden the scope of DNA patents. This paper explores this evolution through a cursory review of the enigmatic written description requirement, examining particularly its history and purposes. It then examines some of the recent cases that allude to this Federal Circuit's policy shift. The paper then attempts to explain this evolution through the application of Public Choice Theory to the Court's decisions.
Document Type: Research Article
Publication date: 2007-06-01
More about this publication?
- Recent Patents on DNA and Gene Sequences publishes review articles by experts on recent patents on DNA and gene sequences. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in applied molecular biology.